We're unable to sign you in at this time. Please try again in a few minutes.
We were able to sign you in, but your subscription(s) could not be found. Please try again in a few minutes.
There may be a problem with your account. Please contact the AMA Service Center to resolve this issue.
Contact the AMA Service Center:
Telephone: 1 (800) 262-2350 or 1 (312) 670-7827  *   Email: subscriptions@jamanetwork.com
Error Message ......
Viewpoint |

Genetic Testing for Inherited Eye Disease Who Benefits?

Janey L. Wiggs, MD, PhD1; Eric A. Pierce, MD, PhD1
[+] Author Affiliations
1Harvard Medical School, Massachusetts Eye and Ear Infirmary, Boston, Massachusetts
JAMA Ophthalmol. 2013;131(10):1265-1266. doi:10.1001/jamaophthalmol.2013.4509.
Text Size: A A A
Published online


New technologies such as next-generation sequencing are rapidly facilitating the discovery of genes responsible for inherited eye disease, an essential step toward the development of clinically useful gene-based diagnostic tests (genetic testing) and gene-based therapies. In the general guidelines for genetic testing for inherited eye disorders recently published by the American Academy of Ophthalmology Task Force,1 testing has been recommended for disorders where the causative genes are known. Disease-causing genes are now known for many inherited ocular disorders, making testing possible for an increasingly large number of diseases. For many eye diseases, genetic tests can confirm the diagnosis and identify patients and family members at risk for the disease. While diagnostic confirmation and family risk assessment are clinically useful, genetic testing is particularly valuable when the treatment and counseling plan is dictated by the disease-causing mutation. Ocular disorders in this category include inherited retinal degenerations (IRDs) and other inherited retinal disorders, early-onset glaucoma, and inherited optic neuropathies.

Sign in

Purchase Options

• Buy this article
• Subscribe to the journal
• Rent this article ?

First Page Preview

View Large
First page PDF preview





Also Meets CME requirements for:
Browse CME for all U.S. States
Accreditation Information
The American Medical Association is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. The AMA designates this journal-based CME activity for a maximum of 1 AMA PRA Category 1 CreditTM per course. Physicians should claim only the credit commensurate with the extent of their participation in the activity. Physicians who complete the CME course and score at least 80% correct on the quiz are eligible for AMA PRA Category 1 CreditTM.
Note: You must get at least of the answers correct to pass this quiz.
Please click the checkbox indicating that you have read the full article in order to submit your answers.
Your answers have been saved for later.
You have not filled in all the answers to complete this quiz
The following questions were not answered:
Sorry, you have unsuccessfully completed this CME quiz with a score of
The following questions were not answered correctly:
Commitment to Change (optional):
Indicate what change(s) you will implement in your practice, if any, based on this CME course.
Your quiz results:
The filled radio buttons indicate your responses. The preferred responses are highlighted
For CME Course: A Proposed Model for Initial Assessment and Management of Acute Heart Failure Syndromes
Indicate what changes(s) you will implement in your practice, if any, based on this CME course.


Some tools below are only available to our subscribers or users with an online account.

7 Citations

Sign in

Purchase Options

• Buy this article
• Subscribe to the journal
• Rent this article ?

Related Content

Customize your page view by dragging & repositioning the boxes below.

Articles Related By Topic
Related Collections